Mu, Rong-Fang
Niu, Yan-Fen
Wang, Qian
Zhou, Hui-Min
Hu, Jing
Qin, Wan-Ying
Xiong, Wen-Yong http://orcid.org/0000-0001-9174-3667
Funding for this research was provided by:
Yunnan Provincial Science and Technology Department (2017FA044, 2013HA023)
National Key R&D Program of China (2017YFC1700906)
Article History
Received: 17 March 2020
Accepted: 4 April 2020
First Online: 20 April 2020
Change Date: 16 June 2020
Change Type: Correction
Change Details: In the original publication of this article, we found an error under the section ���Introduction���. The first sentence of the fourth paragraph appears incorrectly. The corrected sentence is given below. Eriocalyxin B, isolated and identified in 1982 [1], is the major component in Chinese plant Isodon eriocalyx (Dunn.) Hara (family Lamiaceae) showing many pharmacological activities, such as inhibiting inflammatory response, regulating immune cell differentiation, inhibiting tumor cells proliferation, causing cell cycle arrest affecting angiogenesis and promoting cancer cells apoptosis.
Compliance with Ethical Standards
:
: The authors declare no competing financial interest.